Altor Fund V Bids for Sleep Cycle AB in Wellness Push

Altor Fund V, through its entity Snark BidCo AB, has launched a public tender offer to acquire all shares of sleep tracking specialist Sleep Cycle AB (publ). The offer values the company at approximately 497 million Swedish kronor (roughly $47.3 million USD), with each share being purchased for 24.50 SEK in cash. This move signals Altor's strategic intent to build a consolidated wellness-focused business group, leveraging Sleep Cycle's established technology and scientific expertise.

The acquisition proposal comes with significant backing, as major shareholders Maciej Drejak (founder and inventor) via his entities h265 AB and MCGA AB, alongside GLA Invest SA, have irrevocably committed to tender their combined 62.9% stake. This substantial commitment from key stakeholders significantly de-risks the transaction for Altor, suggesting strong alignment on the future direction of Sleep Cycle.

The offer represents a compelling premium for public shareholders. At 24.50 SEK per share, the bid is approximately 47% higher than Sleep Cycle's closing price on May 8, 2026, the last trading day prior to the announcement. It also reflects a premium of around 46% and 49% over the 30-day and 60-day volume-weighted average prices, respectively. This valuation underscores the perceived value of Sleep Cycle's intellectual property and market position within the rapidly growing digital health and wellness sector, a market projected to reach hundreds of billions globally in the coming years.

Altor's rationale for taking Sleep Cycle private centers on providing the company with greater strategic flexibility and financial resources for long-term development. The private equity firm views the challenging market conditions and the inherent risks associated with nascent business areas as better suited for a private ownership structure. This approach allows for the patient, long-term financial commitments necessary to execute ambitious strategic initiatives without the short-term pressures often associated with public markets.

Furthermore, Altor intends to integrate Sleep Cycle into a broader wellness conglomerate. The firm has already invested in Audiowell, a lifestyle-focused music company, which is slated to be part of this emerging group. The synergy expected from combining these and future acquisitions is anticipated to drive mutual benefits and shared competencies, capitalizing on the global surge in consumer interest in well-being and personal health.

While Altor emphasizes that no immediate decisions have been made regarding material changes to Sleep Cycle's current workforce or operations, the integration into a larger wellness group may necessitate future organizational adjustments. The firm has stated that any such changes would be determined after the offer's completion and a comprehensive evaluation of the combined entity. The offer is contingent on Snark BidCo acquiring over 90% of the total shares and securing necessary regulatory approvals, with the acceptance period expected to run from late May to late June 2026.